Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - KalVista Pharmaceuticals, Inc. | StockGist | StockGist

Companies
KALV
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings KALVSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

KalVista Pharmaceuticals, Inc.

Filed Feb 3, 2025

Accepted Feb 2, 2025, 7:00 PM ET

CIK 0001348911

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

0

Reporting Person

KalVista Pharmaceuticals, Inc.

Person Type

PN

CUSIP: 03828A101

Amendment History

6 filings

SCHEDULE 13G
Original
Nov 10, 20250001104659-25-109172
SCHEDULE 13G/A
Amendment 1
Viewing
Feb 3, 20250001415889-25-002811
SCHEDULE 13G/A
Amendment 2
May 13, 20250001422848-25-000121
SCHEDULE 13G/A
Amendment 3
May 15, 20250001214659-25-007877
SCHEDULE 13G/A
Amendment 4
Nov 14, 20250000902664-25-004989
SCHEDULE 13G/A
Amendment 5
Latest
Dec 30, 20250001104659-25-125246

Key Facts

Shares Owned

0

Recent Filings

KalVista Pharmaceuticals, Inc.1 weeks ago

KalVista Pharmaceuticals, Inc.2 months ago

KalVista Pharmaceuticals, Inc.2 months ago

KalVista Pharmaceuticals, Inc.2 months ago

KalVista Pharmaceuticals, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice